Health Tech
World EPA Congress
Evidence, Pricing and Access is Europe’s largest congress in market access, pricing and evidence featuring 250 speakers, multiple streams and over 1500 attendees from pharma, biotech and Payers/ HTA’s.
The essentials
Event details
- Dates
- 2 March 2027 to 3 March 2027
- Organiser
- Terrapinn Holdings Ltd
- Tickets
- EUR 600
- Expected attendance
- 1,600
- Industry
- Health Tech
Who attends
The audience
The World Evidence, Pricing and Access Congress is Europe’s largest congress in market access, pricing and evidence featuring 250 speakers, 10 tracks and 1600+ attendees from pharma, biotech and Payers/HTA’s.
As described by the organiser
Public discussion
What people are saying
Official hashtag #worldepacongress
- VideoWorld EPA Congress 2026: Accelerating access to CGP
Comprehensive genomic profiling (CGP) has the potential to transform care — but access remains uneven across Europe. Herbert Altmann, Vice President, Market ...
- VideoWorld EPA Congress 2026: IRP explained
International reference pricing (IRP) looks simple on paper — but rarely is in practice.Casper Paardekooper, VP, Head of Pricing, Policy & Stakeholder Engage...
- VideoWhat is YHEC? Profile for the World EPA Congress 2026
If you want to find out more about YHEC, speak with our representatives at the World EPA Congress 2026 or contact us: https://www.yhec.co.uk/contact-us/
Speaking
Call for speakers
This event publishes a call for speakers. The deadline is unverified, so check the call before preparing a submission.
Agenda themes
Topics covered
- market access
- pricing
- reimbursement
- rare diseases
- health technology assessments
- health economics and outcomes research
On stage
Speakers
- Alex Bastian, Vice President, Commercial Strategy, Memo Therapeutics
- Toon Digneffe, Head Public Affairs & Public Policy, Takeda
- Jag Chhatwal, Director, Center for Health Technology Assessment, Harvard Medical School
- Sally Chung, Ipsen
- Eva Susanne Dietrich, Professor, Departments for Clinical Pharmacy and Regulatory Affairs, University of Bonn
- Ayman Semaan, Head of Market Access & Pricing, Biologix
- Jiri Smejkal, Access & Value Head PDT, Takeda
- Yvette Venable, Global Senior Director of Payer Partnerships and Policy, AstraZeneca
- Reg Waldeck, Vice President, Head Global Market Access, Bayer
- Marieangela Economopoulou, Head of Access & External Affairs SEE Region, UCB
- Gavin Lewis, Senior Vice President, Head of Value and Access, Novartis
On the floor
Sponsors and partners
- Lifescience Dynamics Ltd
- Parexel International LLC
- Valid Insight
- Clinigen Group
- CRA, Charles River Associates
- Acumetis
- Lyfegen
- Red Nucleus
- Remap Consulting
- Windrose Consulting Group
- Access Infinity
- EVERSANA
- Genesis Research Group
- Initiate Consultancy
- Kintiga (MAP Patient Access)
- RTI Health Solutions
- Pharmacoevidence
- Precision AQ
- Red Thread Market Access Ltd
- STRATENYM
- Wickenstones
- AESARA
- Asc Academics
- Cellbyte
Logistics
Where to stay
Places to stay near the venue.
Die Port van Cleve
176 Nieuwezijds Voorburgwal, Amsterdam, 1012SJ
W Amsterdam
175 Spuistraat, Amsterdam, 1012VN
Hotel Tamara
144 Nieuwezijds Voorburgwal, Amsterdam, 1012SJ
The Times
135-137 Herengracht, Amsterdam, 1015BG
Dam Square Inn
12-16 Gravenstraat, Amsterdam, 1012NM
´t Hotel
18 Leliegracht, Amsterdam, 1015DE
Soho House
210 Spuistraat, Amsterdam, 1012VT
Di-Ann City Centre Hotel ★★
27 Raadhuisstraat, Amsterdam, 1016DC
Keep planning
Related events
Spot something wrong on this page? Report a correction and we will fix it.